ImageneBio, Inc.

NasdaqCM:IMA Stock Report

Market Cap: US$62.3m

ImageneBio Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqCM:IMA Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
25 Jul 25BuyUS$2,499,969OrbiMed Advisors LLCCompany83,611US$29.90
25 Jul 25BuyUS$7,999,924Omega Fund Management, LLCCompany267,556US$29.90

Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of IMA?
Owner TypeNumber of SharesOwnership Percentage
Private Companies62,6790.588%
Individual Insiders158,7871.49%
Hedge Funds802,1027.53%
Public Companies971,1739.12%
VC/PE Firms2,328,70921.9%
Institutions2,339,70722%
General Public3,987,79937.4%

Dilution of Shares: IMA only recently listed within the past 12 months


Top Shareholders

Top 25 shareholders own 61.94% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
9.12%
enGene Holdings Inc.
971,173US$5.7m0%no data
8.54%
OrbiMed Advisors LLC
909,269US$5.3m0%0.07%
8.25%
Deep Track Capital, LP
878,516US$5.1m0%0.09%
7.53%
BVF Partners L.P.
802,102US$4.7m0%0.12%
5.08%
CHI Advisors LLC
540,924US$3.2m0%1.61%
4.28%
Omega Fund Management, LLC
455,361US$2.7m0%0.78%
3.55%
Atlas Venture Advisors, Inc.
377,814US$2.2m0%0.24%
3.14%
RTW Investments, LP
334,445US$2.0m0%0.02%
2.19%
The Vanguard Group, Inc.
233,358US$1.4m0%no data
1.77%
HighLight Capital
188,042US$1.1m0%2.15%
1.71%
BML Capital Management, LLC
182,509US$1.1m0%0.76%
1.35%
Jonathan Jian Wang
143,832US$841.4k0%no data
1.15%
Citadel Advisors LLC
122,247US$715.1k0%no data
0.63%
Adage Capital Management, L.P.
66,666US$390.0k0%no data
0.49%
BlackRock, Inc.
52,111US$304.8k0%no data
0.47%
HLC GP III Company Limited
50,144US$293.3k0%no data
0.47%
New Enterprise Associates, Inc.
50,005US$292.5k0%0.01%
0.45%
Geode Capital Management, LLC
47,688US$279.0k0%no data
0.42%
XTX Markets Limited
44,951US$263.0k0%0.01%
0.35%
Renaissance Technologies LLC
37,378US$218.7k0%no data
0.3%
Sofinnova Investment, Inc.
31,884US$186.5k0%0.01%
0.23%
Squarepoint OPS LLC
24,170US$141.4k0%no data
0.18%
Aldebaran Capital, LLC
19,562US$114.4k0%0.1%
0.17%
Jacobs Levy Equity Management Inc
17,708US$103.6k0%no data
0.14%
Rangeley Capital, LLC
15,000US$87.7k0%0.07%

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/12/26 00:53
End of Day Share Price 2025/12/26 00:00
Earnings2025/09/30
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

ImageneBio, Inc. is covered by 3 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David RisingerLeerink Partners LLC
Yu FanWedbush Securities Inc.
Matthew PhippsWilliam Blair & Company L.L.C.